First, both LRP5 and LRP6 are key therapeutic targets for treatment of human diseases including cancer and/or osteoporosis; and secondly, LRP5 and LRP6 share five virtually identical orthologous PPPSPxS motifs, implying that other unknown mechanisms may operate to tune the Wnt receptor activities through these motifs. The gene discussed is LRP5; the disease is osteoporosis.